Company Response
West Coast Equity Partners LLC has not responded to
Timeline
-
U.S. Securities and Exchange Commission (SEC) did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Migdal did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Glazer Capital did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Phoenix Holdings did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Light Street Capital Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Millennium Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Empyrean Capital Partners did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Citadel did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
683 Capital Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Crescent Park Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Makena Capital Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
West Coast Equity Partners did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Weiss Asset Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Park West Asset Management did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Nasdaq did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Crosslink Capital did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Axon Enterprise did not respond to open letter regarding risks to human rights from Cellebrite’s technologies
-
Open Letter: Cellebrite should not go public without demonstrating human rights compliance
Access Now and other civil society organizations are urging the US Securities and Exchange Commission (SEC), NASDAQ, and other stakeholders to stop deal with Israeli digital intelligence firm Cellebrite, which sells products posing risks to human rights.
View full story